Study Objectives

Primary Objectives:  

• To implement a multicomponent programmatic intervention geared at fostering earlier detection of cancers.
• To evaluate the impact of the above on cancer stage at diagnosis and time to cancer treatment initiation

Secondary Objectives:

• To identify predictors of delayed diagnosis and delayed initiation of treatment.
• To further evaluate impact of the study intervention through assessment of change in healthcare provider knowledge and satisfaction.
• To characterize barriers to care of patients who miss clinical appointments.
• To develop an in-service training curriculum to foster early detection of cancer, with potential to be scaled up nationally

Study Design: A prospective open cohort study, with participants that includes;

• Patients suspected to have cancer who are referred up from primary public health facilities in Kweneng East district for evaluation of cancer care.
• Health care providers at these facilities

Study Population: Women of childbearing age in Botswana (either living with HIV and using DTG-based ART or without HIV infection and ART naïve) who have already chosen to use the LNG subdermal implant or the DMPA injectable for contraceptive protection.

Study Duration: 5 years.

Sponsor: National Institutes of Health (NIH).